MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

Mersana Therapeutics Inc

Open

SectorHealthcare

8.15 5.84

Overview

Share price change

24h

Current

Min

7.64

Max

8.2

Key metrics

By Trading Economics

Income

-173K

-24M

Sales

302K

3.1M

Profit margin

-795.026

Employees

102

EBITDA

-303K

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+345.84% upside

Dividends

By Dow Jones

Next Earnings

12 lis 2025

Market Stats

By TradingEconomics

Market Cap

9.1M

39M

Previous open

2.31

Previous close

8.15

News Sentiment

By Acuity

34%

66%

97 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Mersana Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 sty 2025, 12:00 UTC

Major Market Movers

Mersana Shares Rise on Advances With Breast-Cancer Treatment

Peer Comparison

Price change

Mersana Therapeutics Inc Forecast

Price Target

By TipRanks

345.84% upside

12 Months Forecast

Average 35.4 USD  345.84%

High 50 USD

Low 17 USD

Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.311 / 0.355Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

No Evidence

Sentiment

By Acuity

97 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat